Mosha-L 4mg/2.5mg Tablet DT
By Mosha-L
Rx
10 Tablet DT in a Strip

Composition
Levocetirizine(4mg) + Montelukast(2.5mg)

Manufacturer - Aamorb Pharmaceuticals Pvt Ltd
ug-47-48, bansi plaza, 581/5, mahatma gandhi rd, near indraprastha tower, new palasia, indore, madhya pradesh 452001

Expires on or after
August, 2025

liver
Caution should be exercised when using Mosha-L 4mg/2.5mg Tablet DT in patients with severe liver disease. It may be necessary to adjust the dosage of the medication in these cases, and it is advisable to consult with your doctor before starting treatment. There is limited information on the use of Mosha-L 4mg/2.5mg Tablet DT in patients with liver issues. However, for those with mild to moderate liver disease, no dose adjustment is typically required.

kidney
Mosha-L 4mg/2.5mg Tablet DT requires caution in patients with kidney disease. Dosage adjustment may be necessary. Avoid use in severe kidney disease. Always consult your doctor for guidance.

alcohol
Caution is recommended when using alcohol with Mosha-L 4mg/2.5mg Tablet DT. It is advised to consult your doctor for guidance.

driving
When taking Mosha-L 4mg/2.5mg Tablet DT, be cautious while driving as it may reduce alertness, affect vision, and cause drowsiness or dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Mosha-L 4mg/2.5mg Tablet DT is generally safe during pregnancy based on animal studies showing minimal adverse effects. Limited human studies are available.

breastfeeding
Mosha-L 4mg/2.5mg Tablet DT is not safe during breastfeeding as it may harm the baby. We advise caution as there is a risk of toxicity to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹59.5
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025